Khashayar Fakhrian

Summary

Publications

  1. doi request reprint Cisplatin- vs. oxaliplatin-based radiosensitizing chemotherapy for squamous cell carcinoma of the esophagus: a comparison of two preoperative radiochemotherapy regimens
    K Fakhrian
    Department of Radiation Oncology, Marien Hospital Herne, University Clinic of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany
    Strahlenther Onkol 190:987-92. 2014
  2. ncbi request reprint Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution
    Khashayar Fakhrian
    Department of Radiation Oncology, Marien Hospital Herne and Sankt Josef Hospital Bochum, Ruhr Universitat Bochum, Bochum, Germany
    Strahlenther Onkol 190:1133-40. 2014
  3. doi request reprint Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Str 22, 81675, Munchen, Germany
    Strahlenther Onkol 188:56-61. 2012
  4. doi request reprint Salvage radiotherapy in patients with recurrent esophageal carcinoma
    K Fakhrian
    Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Strasse 22, Munich, Germany
    Strahlenther Onkol 188:136-42. 2012
  5. doi request reprint Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Retrospective analysis of a series of 50 patients
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Strahlenther Onkol 188:464-70. 2012
  6. doi request reprint Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute
    K Fakhrian
    Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Strahlenther Onkol 189:18-25. 2013
  7. doi request reprint Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger St 22, Munich, Germany
    Strahlenther Onkol 189:293-300. 2013
  8. doi request reprint Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature
    K Fakhrian
    Department of Radiation Oncology, Marienhospital Herne, Universitätsklinikum der Ruhr Universität Bochum, Hölkeskampring 40, Herne, Germany
    Strahlenther Onkol 189:486-94. 2013
  9. doi request reprint Primary radiotherapy with or without chemotherapy in non-metastatic esophageal squamous cell carcinoma: a retrospective study
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitaet Muenchen
    Dis Esophagus 25:256-62. 2012
  10. ncbi request reprint Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model
    Veria Khosrawipour
    Department of General Surgery and Therapy Center for Peritoneal Carcinomatosis, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany Basic Research Laboratory, Department of Surgery, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany
    Anticancer Res 36:4595-600. 2016

Collaborators

  • H Geinitz
  • Jürgen Zieren
  • Irenaus A Adamietz
  • Florian Lordick
  • Ralph Mücke
  • V Bisof
  • J Theisen
  • C Bayer
  • Kristin Deinbeck
  • A Dinkel
  • Veria Khosrawipour
  • Philipp Günther Kup
  • Carsten Nieder
  • David Díaz-Carballo
  • Eckart Forster
  • Helmut Buhler
  • Arif Deniz Ordu
  • Tanja Khosrawipour
  • Julia Welsch
  • Alexander Gitt
  • Hugo Böse-Ribeiro
  • Aras Osma
  • Burak Kabakci
  • Vera Scherer
  • Stephanie E Combs
  • Alexander Jens Peter Kern
  • Yousef Hedayat Pour
  • Carolina Khosrawipour
  • Alexander Bellendorf
  • Urs Giger-Pabst
  • Clemens Hoberg
  • Dorothee Drüppel
  • Horst Hermani
  • Thomas Albert Falkenstein
  • Guido Winnekendonk
  • Yousef Hedayat-Pour
  • Hasan Yavuz Ergönenç
  • Lisa Felicia Deymann
  • Tibor Schuster

Detail Information

Publications21

  1. doi request reprint Cisplatin- vs. oxaliplatin-based radiosensitizing chemotherapy for squamous cell carcinoma of the esophagus: a comparison of two preoperative radiochemotherapy regimens
    K Fakhrian
    Department of Radiation Oncology, Marien Hospital Herne, University Clinic of the Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany
    Strahlenther Onkol 190:987-92. 2014
    ..To compare the outcomes of two neoadjuvant radiochemotherapy (N-RCT) regimens for squamous cell carcinoma of the esophagus (ESCC)...
  2. ncbi request reprint Long-term outcomes of trimodality treatment for squamous cell carcinoma of the esophagus with cisplatin and/or 5-FU: more than 20 years' experience at a single institution
    Khashayar Fakhrian
    Department of Radiation Oncology, Marien Hospital Herne and Sankt Josef Hospital Bochum, Ruhr Universitat Bochum, Bochum, Germany
    Strahlenther Onkol 190:1133-40. 2014
    ..The purpose of this article is to report the outcome of neoadjuvant radiochemotherapy (N-RCT) + surgery in patients with squamous cell carcinoma of the esophagus at a single institution...
  3. doi request reprint Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Str 22, 81675, Munchen, Germany
    Strahlenther Onkol 188:56-61. 2012
    ..The goal was to retrospectively review the outcome of patients with cervical lymph node metastases of squamuos cell carcinoma of unknown primary site (CUP) treated with radio(chemo)therapy...
  4. doi request reprint Salvage radiotherapy in patients with recurrent esophageal carcinoma
    K Fakhrian
    Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger Strasse 22, Munich, Germany
    Strahlenther Onkol 188:136-42. 2012
    ..The feasibility and effectiveness of radiotherapy in the management of recurrent esophageal carcinoma (REC) is reported...
  5. doi request reprint Radiotherapy in stage I-III follicular non-Hodgkin lymphoma. Retrospective analysis of a series of 50 patients
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Strahlenther Onkol 188:464-70. 2012
    ..The goal of this work was to analyze the response rate and outcome of patients with stage I-III follicular lymphoma (FL) treated with radiotherapy (RT) alone...
  6. doi request reprint Radiotherapy with or without chemotherapy in the treatment of anal cancer: 20-year experience from a single institute
    K Fakhrian
    Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Strahlenther Onkol 189:18-25. 2013
    ..To report the efficacy and toxicity of radio(chemo)therapy (RCT) in the management of squamous cell anal carcinoma (SQ-AC) and to evaluate the prognostic factors influencing the outcomes...
  7. doi request reprint Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Ismaninger St 22, Munich, Germany
    Strahlenther Onkol 189:293-300. 2013
    ..The goal of this work was to investigate the potential of advanced radiation techniques in dose escalation in the radiotherapy (RT) for the treatment of esophageal carcinoma...
  8. doi request reprint Chronic adverse events and quality of life after radiochemotherapy in anal cancer patients. A single institution experience and review of the literature
    K Fakhrian
    Department of Radiation Oncology, Marienhospital Herne, Universitätsklinikum der Ruhr Universität Bochum, Hölkeskampring 40, Herne, Germany
    Strahlenther Onkol 189:486-94. 2013
    ..To report on chronic adverse events (CAE) and quality of life (QOL) after radiochemotherapy (RCT) in patients with anal cancer (AC)...
  9. doi request reprint Primary radiotherapy with or without chemotherapy in non-metastatic esophageal squamous cell carcinoma: a retrospective study
    K Fakhrian
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitaet Muenchen
    Dis Esophagus 25:256-62. 2012
    ..The introduction of modern treatment techniques/modalities (3D conformal planning/ continuous standard fractionation) might be associated with better outcomes...
  10. ncbi request reprint Evaluating the Effect of Micropump© Position, Internal Pressure and Doxorubicin Dosage on Efficacy of Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model
    Veria Khosrawipour
    Department of General Surgery and Therapy Center for Peritoneal Carcinomatosis, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany Basic Research Laboratory, Department of Surgery, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany
    Anticancer Res 36:4595-600. 2016
    ....
  11. pmc Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model
    Veria Khosrawipour
    1 Department of General Surgery and Therapy Center for Peritonealcarcinomatosis, Marien Hospital Herne, Ruhr University Bochum, Germany 2 Basic Research Laboratory, Department of Surgery, Marien Hospital Herne, Ruhr University Bochum, Germany
    J Cancer 7:910-4. 2016
    ..This study was performed to assess the impact of irradiation on the tissue penetration depth of doxorubicin delivered during Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC)...
  12. doi request reprint Outcomes of patients with squamous cell carcinoma of esophagus who did not receive surgical resection after neoadjuvant radiochemotherapy
    Khashayar Fakhrian
    2 Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich Germany
    Tumori 101:263-7. 2015
    ....
  13. doi request reprint Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus: long-term outcome
    Arif Deniz Ordu
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Strahlenther Onkol 191:153-60. 2015
    ..The purpose of this work is to report the long-term outcomes of three-dimensional conformal radio(chemo)therapy in the curative management of esophageal squamous cell carcinoma (ESCC)...
  14. pmc Survival and Symptom Relief after Palliative Radiotherapy for Esophageal Cancer
    Julia Welsch
    1 Department of Radiation Oncology, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany
    J Cancer 7:125-30. 2016
    ..The aim of this study was to assess the 6-months dysphagia-free survival, improvement in swallowing function, complication rate, and overall survival in patients with incurable esophageal cancer treated with palliative radiotherapy...
  15. doi request reprint Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model
    Veria Khosrawipour
    Department of General Surgery and Therapy Center for Peritonealcarcinomatosis, Marien Hospital Herne, Ruhr University Bochum, Hölkeskampring 40, 44625, Herne, Germany
    J Cancer Res Clin Oncol 142:2275-80. 2016
    ..This study was conducted to evaluate the distribution pattern of doxorubicin in the abdominal cavity after PIPAC in a postmortem swine model...
  16. pmc Extracranial oral cavity metastasis from glioblastoma multiforme: A case report
    Philipp Günther Kup
    Department of Radiation Oncology, Marien Hospital Herne, Ruhr University Bochum, D 44625 Herne, Germany Department of Radiation Oncology, St Josef Hospital Bochum, Ruhr University Bochum, D 44791 Bochum, Germany
    Mol Clin Oncol 5:437-439. 2016
    ....
  17. ncbi request reprint Association between radiation dose and pathological complete response after preoperative radiochemotherapy in esophageal squamous cell cancer
    Arif Deniz Ordu
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munchen, Germany
    Anticancer Res 34:7255-61. 2014
    ..This study was undertaken to examine the impact of radiation dose on pathological complete response (pCR) rates following neoadjuvant radiochemotherapy (N-RCT) for squamous cell esophageal cancer (ESCC)...
  18. pmc Radiotherapy in marginal zone lymphoma
    Kristin Deinbeck
    Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universitat Munchen, Munich, Germany
    Radiat Oncol 8:2. 2013
    ..To evaluate the efficacy of radiotherapy (RT) for early-stage nodal and extranodal marginal zone lymphoma (MZL)...
  19. ncbi request reprint Treatment Results of MammoSite Catheter in Combination with Whole-breast Irradiation
    Alexander Gitt
    Department of Radiation Oncology, Marien Hospital Herne, Ruhr University Bochum, Bochum, Germany
    Anticancer Res 36:355-60. 2016
    ..To report the initial outcomes of patients treated with the MammoSite brachytherapy device (MSBT) as a boost followed by external whole-breast irradiation (WBI)...
  20. ncbi request reprint Irradiation Does Not Increase the Penetration Depth of Doxorubicin in Normal Tissue After Pressurized Intra-peritoneal Aerosol Chemotherapy (PIPAC) in an Ex Vivo Model
    Veria Khosrawipour
    Department of General Surgery and Therapy Center for Peritonealcarcinomatosis, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany Basic Research Laboratory, Department of Surgery, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany
    In Vivo 30:593-7. 2016
    ..To compare the impact of single fractional with bi-fractional irradiation on the depth of doxorubicin penetration into the normal tissue after pressurized intra-peritoneal aerosol chemotherapy (PIPAC) in our ex vivo model...
  21. ncbi request reprint Zoledronic Acid Inhibits the Motility of Cancer Stem-like Cells from the Human Breast Cancer Cell Line MDA-MB 231
    Helmut Buhler
    Institute for Radiation Biology, Department of Radiation Oncology, Marien Hospital Herne, Ruhr University Bochum, Herne, Germany
    In Vivo 30:761-768. 2016
    ..However, only limited data exist regarding its influence on the motility of tumor cells. Since migration of tumor stem cells is a decisive step in metastasis, we examined whether ZOL reduces their motility...